Previous terms
of clearance for the privacy impact assessment and firm 225B have
been satisfied.
Inventory as of this Action
Requested
Previously Approved
07/31/2018
36 Months From Approved
07/31/2015
13,589
0
13,097
1,879
0
2,790
158,040
0
5,105,847
The Controlled Substances Act requires
all businesses and individuals who manufacture, distribute, import,
export, and conduct research and laboratory analysis with
controlled substances to register with the DEA. 21 U.S.C. 822, 21
CFR 1301.11 and 1301.13. Registration is a necessary control
measure that prevents diversion by ensuring the closed system of
distribution of controlled substances can be monitored by the DEA
and that the businesses and individuals handling controlled
substances are qualified to do so and are accountable.
US Code:
21
USC 822 Name of Law: Persons Required to Register
In prior information collection
requests, the associated registration fee was included in the cost
burden calculation. The DEA believes the registration fee should be
excluded from the information collection cost burden because the
time and capital expense burden to provide the information is not
tied to the registration fee. This change in calculation method is
employed in this and future information collection requests.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.